
Nianxiang Zou
Examiner (ID: 10628, Phone: (571)272-2850 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1671 |
| Total Applications | 845 |
| Issued Applications | 504 |
| Pending Applications | 89 |
| Abandoned Applications | 294 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18565756
[patent_doc_number] => 20230256083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => SELF-AMPLIFYING SARS-COV-2 RNA VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/001912
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001912
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001912 | SELF-AMPLIFYING SARS-COV-2 RNA VACCINE | Jun 17, 2021 | Pending |
Array
(
[id] => 19091203
[patent_doc_number] => 11952637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Rapid low-cost detection of SARS-CoV-2 using isothermal amplification and sensing methods
[patent_app_type] => utility
[patent_app_number] => 18/001395
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 27
[patent_no_of_words] => 10637
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001395
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001395 | Rapid low-cost detection of SARS-CoV-2 using isothermal amplification and sensing methods | Jun 10, 2021 | Issued |
Array
(
[id] => 17244773
[patent_doc_number] => 20210364516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => ULTRA-SENSITIVE, FAST, PLASMONIC-FLUOR ENHANCED ASSAY FOR SARS-COV-2 IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/303063
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17303063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/303063 | ULTRA-SENSITIVE, FAST, PLASMONIC-FLUOR ENHANCED ASSAY FOR SARS-COV-2 IMMUNE RESPONSE | May 18, 2021 | Abandoned |
Array
(
[id] => 18603445
[patent_doc_number] => 11744885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Vaccines for recurrent respiratory papillomatosis and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 17/320944
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28827
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320944 | Vaccines for recurrent respiratory papillomatosis and methods of using the same | May 13, 2021 | Issued |
Array
(
[id] => 17229908
[patent_doc_number] => 20210356465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => NEUTRALIZING ANTIBODY TESTING AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/319081
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319081 | Neutralizing antibody testing and treatment | May 11, 2021 | Issued |
Array
(
[id] => 19389880
[patent_doc_number] => 20240279750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => Diagnostic Primers, Kits and Methods for Viral Detection
[patent_app_type] => utility
[patent_app_number] => 17/923444
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923444 | Diagnostic Primers, Kits and Methods for Viral Detection | May 4, 2021 | Pending |
Array
(
[id] => 18738015
[patent_doc_number] => 20230346920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => VACCINES AGAINST VIRAL PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/997886
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997886 | VACCINES AGAINST VIRAL PATHOGENS | May 3, 2021 | Pending |
Array
(
[id] => 18738015
[patent_doc_number] => 20230346920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => VACCINES AGAINST VIRAL PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/997886
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997886 | VACCINES AGAINST VIRAL PATHOGENS | May 3, 2021 | Pending |
Array
(
[id] => 18406908
[patent_doc_number] => 20230168259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => METHOD FOR PREDICTING THE COURSE OF A VIRAL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/995728
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995728 | METHOD FOR PREDICTING THE COURSE OF A VIRAL DISEASE | Apr 29, 2021 | Pending |
Array
(
[id] => 17784913
[patent_doc_number] => 11408026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Methods of predicting susceptibility to infectious disease and related methods of treatment
[patent_app_type] => utility
[patent_app_number] => 17/240991
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11360
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240991 | Methods of predicting susceptibility to infectious disease and related methods of treatment | Apr 25, 2021 | Issued |
Array
(
[id] => 17193400
[patent_doc_number] => 11162143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Methods for generating therapeutic delivery platforms
[patent_app_type] => utility
[patent_app_number] => 17/236561
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 50
[patent_no_of_words] => 28015
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236561
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236561 | Methods for generating therapeutic delivery platforms | Apr 20, 2021 | Issued |
Array
(
[id] => 16990286
[patent_doc_number] => 20210228706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => IMMUNE COMPLEX
[patent_app_type] => utility
[patent_app_number] => 17/301626
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301626 | Immune complex | Apr 8, 2021 | Issued |
Array
(
[id] => 18610915
[patent_doc_number] => 20230277645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA
[patent_app_type] => utility
[patent_app_number] => 17/221032
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221032 | COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA | Apr 1, 2021 | Pending |
Array
(
[id] => 18610915
[patent_doc_number] => 20230277645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA
[patent_app_type] => utility
[patent_app_number] => 17/221032
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221032 | COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA | Apr 1, 2021 | Pending |
Array
(
[id] => 18296431
[patent_doc_number] => 20230106117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/909688
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909688 | SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES | Mar 7, 2021 | Pending |
Array
(
[id] => 17065882
[patent_doc_number] => 20210268097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/194779
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194779
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194779 | Vaccines against HPV and HPV-related diseases | Mar 7, 2021 | Issued |
Array
(
[id] => 18420616
[patent_doc_number] => 20230175079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => METHOD FOR DETECTING SINGLE-STRANDED RNA VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/904897
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 382
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904897 | METHOD FOR DETECTING SINGLE-STRANDED RNA VIRUS | Feb 23, 2021 | Pending |
Array
(
[id] => 18737804
[patent_doc_number] => 20230346700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/800687
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800687 | Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors | Feb 18, 2021 | Pending |
Array
(
[id] => 19210919
[patent_doc_number] => 11999967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Generating HPV antigen-specific cells from a naive T cell population
[patent_app_type] => utility
[patent_app_number] => 17/168461
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6271
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168461 | Generating HPV antigen-specific cells from a naive T cell population | Feb 4, 2021 | Issued |
Array
(
[id] => 18335859
[patent_doc_number] => 20230127808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => AD7-VECTORED VACCINE FOR PREVENTING SARS- COV-2 INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/598659
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598659 | AD7-VECTORED VACCINE FOR PREVENTING SARS- COV-2 INFECTION | Feb 1, 2021 | Pending |